Establishment of an experimental human lung adenocarcinoma cell line SPC-A-1BM with high bone metastases potency by 99mTc-MDP bone scintigraphy

Nuclear Medicine and Biology

Volumn 36, Issue 3, 2009, Pages 313-321

  Yang, Shunfang ^a   Dong, Qianggang ^a   Yao, Ming ^a   Shi, Meiping ^a   Ye, Jianding ^a   Zhao, Langxiang ^a   Su, Jianzhong ^a   Gu, Weiyong ^a   Xie, Wenhui ^a   Wang, Kankan ^a   Du, Yanzhi ^a   Li, Yao ^b   Huang, Yan ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Bone metastasis; Bone scintigraphy; Human lung adenocarcinoma; In vivo imaging; Real time PCR

Indexed keywords

MEDRONATE TECHNETIUM TC 99M;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER CELL CULTURE; CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; HEART VENTRICLE; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADENOCARCINOMA; ANIMALS; BONE AND BONES; BONE NEOPLASMS; CELL LINE, TUMOR; HUMANS; LUNG NEOPLASMS; MICE; POLYMERASE CHAIN REACTION; TECHNETIUM TC 99M MEDRONATE; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; WHOLE BODY IMAGING;

EID: 62549110829     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2008.12.007     Document Type: Article

References (33)

1. Yang R.P., and Qu W.Y. Characterization of lung adenocarcinoma bone metastasis from different histological samples. Chin J Nucl Med 12 (1992) 24-26
2. Sugiura H., Yamada K., Sugiura T., Hida T., and Mitsudomi T. Predictors of survival in patients with bone metastasis of lung cancer. Clin Orthop Relat Res 466 (2008) 729-736
3. Arguello F., Baggs R.B., and Frantz C.N. A murine model of experimental metastasis to bone and bone marrow. Cancer Res 48 (1988) 6876-6881
4. Sasaki A., Boyce B.F., Story B., Wright K.R., Chapman M., Boyce R., et al. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res 55 (1995) 3551-3557
5. Rabbani S.A., Harakidas P., Bowlin T., and Attardo G. Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo. Cancer Res 58 (1998) 3461-3465
6. Iguchi H., Tanaka S., Ozawa Y., Kashiwakuma T., Kimura T., Hiraga T., et al. An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis. Cancer Res 56 (1996) 4040-4043
7. Iguchi H., Onuma E., Sato K., Sato K., and Ogata E. Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen. Int J Cancer 94 (2001) 24-27
8. Miki T., Yano S., Hanibuchi M., Kanematsu T., Muguruma H., and Sone S. Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice. Int J Cancer 108 (2004) 511-515
9. Price J.E. Metastasis from human breast cancer cell lines. Breast Cancer Res Treat, 39 (1996) 93-102
10. Lecouvet F.E., Vande Berg B.C., Malghem J., and Maldague B.E. Magnetic resonance and computed tomography imaging in multiple myeloma. Semin Musculoskelet Radiol 5 (2001) 43-55
11. Andriole G.L., Mule J.J., Hansen C.T., Linehan W.M., and Rosenberg S.A. Evidence that lymphokine-activated killer cells and natural killer cells are distinct based on an analysis of congenitally immunodeficient mice. J Immunol 135 (1985) 2911-2913
12. Kollmann T.R., Goldstein M.M., and Goldstein H. The concurrent maturation of mouse and human thymocytes in human fetal thymus implanted in NIH-beige-nude-xid mice is associated with the reconstitution of the murine immune system. J Exp Med 177 (1993) 821-832
13. Arguello F., Furlanetto R.W., Baggs R.B., Graves B.T., Harwell S.E., Cohen H.J., et al. Incidence and distribution of experimental metastases in mutant mice with defective organ microenvironments (genotypes Sl/Sld and W/Wv). Cancer Res 52 (1992) 2304-2309
14. Casini Raggi C., Calabro A., Renzi D., Briganti V., Cianchi F., Messerini L., et al. Quantitative evaluation of somatostatin receptor subtype 2 expression in sporadic colorectal tumor and in the corresponding normal mucosa. Clin Cancer Res 8 (2002) 419-427
15. Liotta L.A. Mechanisms of cancer invasion and metastasis. In: DeVita V.T., Hellman S., and Rosenberg S.A. (Eds). Important advances in oncology (1985), J. B. Lippincott, New York 28-41
16. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79 (1994) 315-328
17. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
18. Mareel M., and Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83 (2003) 337-376
19. Wang L., Yu J., Ni J., Xu X.M., Wang J., Ning H., et al. Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors. Cancer Lett 200 (2003) 57-67
20. Clark E.A., Golub T.R., Lander E.S., and Hynes R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406 (2000) 532-535
21. Bittner M., Meltzer P., Chen Y., Jiang Y., Seftor E., Hendrix M., et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406 (2000) 536-540
22. Han S., Ritzenthaler J.D., Sitaraman S.V., and Roman J. Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem 281 (2006) 29614-29624
23. Chang X.Z., Li D.Q., Hou Y.F., Wu J., Lu J.S., Di G.H., et al. Identification of the functional role of AF1Q in the progression of breast cancer. Breast Cancer Res Treat 111 (2008) 65-78
24. Buchholz M., Biebl A., Neesse A., Wagner M., Iwamura T., Leder G., et al. SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo. Cancer Res 63 (2003) 4945-4951
25. Sarrazin S., Adam E., Lyon M., Depontieu F., Motte V., Landolfi C., et al. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta 1765 (2006) 25-37
26. Sone S., and Yano S. Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to bone. Cancer Metastasis Rev 26 (2007) 685-689
27. Rybak L.D., and Rosenthal D.I. Radiological imaging for the diagnosis of bone metastases. Q J Nucl Med 45 (2001) 53-64
28. Even-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. J Nucl Med 46 (2005) 1356-1367
29. Blake G.M., Park-Holohan S.J., Cook G.J., and Fogelman I. Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate. Semin Nucl Med 31 (2001) 28-49
30. Zou H., Zhan S., and Cao K. Apoptotic activity of genistein on human lung adenocarcinoma SPC-A-1 cells and preliminary exploration of its mechanisms using microarray. Biomed Pharmacother (2008) 10.1016/j.biopha.2007.12.010
31. Lukashev M.E., and Werb Z. ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 8 (1998) 437-441
32. Kebebew E., Peng M., Reiff E., Duh Q.Y., Clark O.H., and McMillan A. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg 242 (2005) 353-361
33. Yuan A., Yu C.J., Kuo S.H., Chen W.J., Lin F.Y., Luh K.T., et al. Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. J Clin Oncol 19 (2001) 432-441